midpage
Projects
Sign in to see your projects.
808 F. Supp. 2d 584
S.D.N.Y.
2011
Read the full case

Background

  • Dr. Paula Small, inventor of the '945 Patent, sues Implant Direct and Nobel for patent infringement in the SDNY.
  • Neoss, Inc. and Neoss, Ltd. settled with Small and were dismissed from the case via stipulation endorsed May 2, 2011.
  • Defendants seek production of the Neoss Agreement, arguing it is relevant to damages and other issues under Rule 26(b)(1).
  • Small opposes production, arguing the Neoss Agreement is not relevant to the reasonable royalty or other issues.
  • The court considers whether the Neoss Agreement is discoverable and, if so, whether it is relevant to a reasonable royalty under 35 U.S.C. § 284.
  • The court grants the motion to compel, holding the Neoss Agreement is relevant to determining a reasonable royalty and must be produced.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Is the Neoss Agreement discoverable under Rule 26(b)(1)? Small argues it is not relevant to damages or royalties. Implant Direct and Nobel contend it is relevant to damages and royalty calculations. Yes; Neoss Agreement is discoverable and must be produced.
Is the Neoss Agreement relevant to a reasonable royalty under ResQNet and related authorities? ResQNet indicates litigation-based settlements are not a basis for a royalty. ResQNet allows considering settlement licenses as part of a broader base for a reasonable royalty. Yes; it is relevant to determining a reasonable royalty under Rule 26(b)(1).
Does ResQNet foreclose the use of settlement agreements to determine a reasonable royalty? ResQNet cautions that litigation can skew hypothetical negotiations; settlements may be of minimal probative value. ResQNet endorses considering relevant information including settlements to establish a reasonable royalty. ResQNet permits discovery and consideration of settlement information for a reasonable royalty, with limited probative value.

Key Cases Cited

  • ResQNet.com, Inc. v. Lansa, Inc., 594 F.3d 860 (Fed.Cir.2010) (settlement licenses tied to litigation can be probative but may be of limited relevance)
  • Uniloc USA, Inc. v. Microsoft Corp., 632 F.3d 1292 (Fed.Cir.2011) (hypothetical negotiation damages framework)
  • Wordtech Sys., Inc. v. Integrated Networks Solutions, Inc., 609 F.3d 1319 (Fed.Cir.2010) (royalty determination can rely on the hypothetical negotiation model)
  • Lucent Techs. v. Gateway, Inc., 580 F.3d 1301 (Fed.Cir.2009) (comparing licenses to the hypothetical license must show comparability)
  • Georgia-Pacific Corp. v. U.S. Plywood Corp., 318 F. Supp. 1116 (S.D.N.Y. 1970) (factors for determining a reasonable royalty)
Read the full case

Case Details

Case Name: Small v. NOBEL BIOCARE USA, LLC
Court Name: District Court, S.D. New York
Date Published: Jul 19, 2011
Citations: 808 F. Supp. 2d 584; 2011 WL 3055357; 2011 U.S. Dist. LEXIS 77838; 06 Civ. 0683 (RJH)(JLC)
Docket Number: 06 Civ. 0683 (RJH)(JLC)
Court Abbreviation: S.D.N.Y.
Log In